11-101895062-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_178127.5(ANGPTL5):āc.664G>Cā(p.Glu222Gln) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000255 in 1,569,484 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178127.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANGPTL5 | NM_178127.5 | c.664G>C | p.Glu222Gln | missense_variant, splice_region_variant | 8/9 | ENST00000334289.7 | NP_835228.2 | |
ANGPTL5 | XM_011542735.4 | c.469G>C | p.Glu157Gln | missense_variant, splice_region_variant | 6/7 | XP_011541037.1 | ||
ANGPTL5 | XM_017017466.3 | c.244G>C | p.Glu82Gln | missense_variant, splice_region_variant | 4/5 | XP_016872955.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANGPTL5 | ENST00000334289.7 | c.664G>C | p.Glu222Gln | missense_variant, splice_region_variant | 8/9 | 1 | NM_178127.5 | ENSP00000335255 | P1 | |
ANGPTL5 | ENST00000534527.1 | c.469G>C | p.Glu157Gln | missense_variant, splice_region_variant | 5/5 | 3 | ENSP00000433562 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151978Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000212 AC: 3AN: 1417506Hom.: 1 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 706074
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151978Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74216
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.664G>C (p.E222Q) alteration is located in exon 8 (coding exon 7) of the ANGPTL5 gene. This alteration results from a G to C substitution at nucleotide position 664, causing the glutamic acid (E) at amino acid position 222 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at